For most people on tirzepatide, this translates to roughly 1,200 to 1,500 calories daily for women and 1,500 to 1,800 calories daily for men during active weight loss
SURPASS 2 trial- Semaglutide versus tirzepatide for diabetes (Hba1c and fasting glucose levels) Both Semaglutide (Ozempic) and Tirzepatide are effective treatments for diabetes, helping to lower Hba1c and fasting blood glucose levels effectively
Despite its expense, the long-term benefits of semaglutide for weight loss cant be ignored, providing sustainable outcomes for many looking to improve their health
Paradoxically, whilst long-term weight loss typically improves joint health and reduces osteoarthritis symptoms (as noted in NICE NG226), the transition period may be associated with adjustment-related discomfort
These results are relevant in the context of the FLOW trial that reported a 24% reduction in CKD progression and lower risk of death from cardiovascular-related or kidney-related causes (composite outcome) with the GLP-1 RA semaglutide compared with placebo treatment on top of RAS inhibition
Andrs, K